G

Genpharmasec Ltd
BSE:531592

Watchlist Manager
Genpharmasec Ltd
BSE:531592
Watchlist
Price: 1.27 INR -3.05% Market Closed
Market Cap: 703.2m INR
Section:
 

Relative Value

531592 price has not been updated for more than 2 years. This may indicate that the stock has been delisted.
531592 doesn't have a meaningful market cap.

The Relative Value of one GENPHARMA stock under the Base Case scenario is hidden INR. Compared to the current market price of 1.27 INR, Genpharmasec Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GENPHARMA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
96
vs Industry
13
Median 3Y
4
Median 5Y
4.1
Industry
0.7
More Details
33.2
P/E
P/E
Price to Earnings
33.2
vs History
80
vs Industry
5
Median 3Y
83.6
Median 5Y
83.6
Industry
15.5
More Details
23.5
P/OCF
P/OCF
Price to OCF
23.5
vs History
17
vs Industry
Median 3Y
-30.1
Median 5Y
-33.5
Industry
8.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-30
Median 5Y
-33.7
Industry
14.7
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
96
vs Industry
28
Median 3Y
2.6
Median 5Y
5.7
Industry
1.2
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
96
vs Industry
15
Median 3Y
3.6
Median 5Y
3.9
Industry
0.9
More Details
13.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.5
vs History
88
vs Industry
14
Median 3Y
26.2
Median 5Y
31.9
Industry
4.4
More Details
104
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
104
vs History
44
vs Industry
3
Median 3Y
261.4
Median 5Y
128
Industry
9.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
2
Median 3Y
195.4
Median 5Y
39.5
Industry
12.2
More Details
24
EV/OCF
EV/OCF
Enterprise Value to OCF
24
vs History
17
vs Industry
Median 3Y
-30
Median 5Y
-31
Industry
9.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-32.8
Median 5Y
-33.1
Industry
11.4
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
95
vs Industry
22
Median 3Y
2.5
Median 5Y
6.2
Industry
0.9
More Details

Multiples Across Competitors

GENPHARMA Competitors Multiples
Genpharmasec Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Genpharmasec Ltd
BSE:531592
725.4m INR 1.7 33.2 104 -606.3
JP
Itochu Corp
TSE:8001
15.6T JPY 1.1 16.6 15.9 26.1
JP
Mitsubishi Corp
TSE:8058
14.2T JPY 0.8 20.7 24.9 53.2
JP
Mitsui & Co Ltd
TSE:8031
13.8T JPY 1 15.1 21.3 36.3
US
United Rentals Inc
NYSE:URI
58.5B USD 3.7 23.1 10 17.6
US
W W Grainger Inc
NYSE:GWW
49.2B USD 2.8 28.4 18.6 20.5
US
WW Grainger Inc
XMUN:GWW
41.9B EUR 2.8 28.3 18.5 20.3
JP
Marubeni Corp
TSE:8002
7.6T JPY 0.9 13.3 15.6 24.4
US
Fastenal Co
NASDAQ:FAST
48B USD 6 39.1 26.6 29.6
US
Ferguson Enterprises Inc
NYSE:FERG
44.9B USD 1.4 23 15.7 17.9
JP
Sumitomo Corp
TSE:8053
6.8T JPY 0.9 11.2 14.5 22.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
G
Genpharmasec Ltd
BSE:531592
Average EV/EBITDA: 26
104
N/A N/A
JP
Itochu Corp
TSE:8001
15.9
5%
3.2
JP
Mitsubishi Corp
TSE:8058
24.9
0%
N/A
JP
Mitsui & Co Ltd
TSE:8031
21.3
4%
5.3
US
United Rentals Inc
NYSE:URI
10
7%
1.4
US
W W Grainger Inc
NYSE:GWW
18.6
6%
3.1
US
W
WW Grainger Inc
XMUN:GWW
18.5
6%
3.1
JP
Marubeni Corp
TSE:8002
15.6
0%
N/A
US
Fastenal Co
NASDAQ:FAST
26.6
10%
2.7
US
Ferguson Enterprises Inc
NYSE:FERG
15.7
8%
2
JP
Sumitomo Corp
TSE:8053
14.5
8%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
G
Genpharmasec Ltd
BSE:531592
Average EV/EBIT: 26.9
Negative Multiple: -606.3 		N/A N/A
JP
Itochu Corp
TSE:8001
26.1
N/A N/A
JP
Mitsubishi Corp
TSE:8058
53.2
N/A N/A
JP
Mitsui & Co Ltd
TSE:8031
36.3
N/A N/A
US
United Rentals Inc
NYSE:URI
17.6
6%
2.9
US
W W Grainger Inc
NYSE:GWW
20.5
6%
3.4
US
W
WW Grainger Inc
XMUN:GWW
20.3
6%
3.4
JP
Marubeni Corp
TSE:8002
24.4
N/A N/A
US
Fastenal Co
NASDAQ:FAST
29.6
11%
2.7
US
Ferguson Enterprises Inc
NYSE:FERG
17.9
10%
1.8
JP
Sumitomo Corp
TSE:8053
22.9
N/A N/A

See Also

Summary
GENPHARMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
GENPHARMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GENPHARMA stock valuation using valuation multiples.
Wall Street Estimates
GENPHARMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GENPHARMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.